Moderna said it will apply Monday for emergency authorization from the FDA for its coronavirus vaccine, becoming the second developer to do so. It will also apply for conditional approval from the European Medicines Agency.
Final results from Moderna's late-stage vaccine trial with 30,000 people show the shot is 94.1 percent effective, the company said.
To change your alert settings, please go to https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings.
This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA
Please click here and follow the steps to unsubscribe.
No comments:
Post a Comment